Keywords: clinical, proof-of-concept, rna, dmd, drug, netherlands, leiden

Clinical proof-of-concept for RNA DMD drug

Article | 07 January 2008

Print This

The Netherlands' Leiden University Medical Center (LUMC) and Dutch biotechnology firm Prosensa say that positive results from the first ever ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in